- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
GCLC Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP18483c | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP18483c-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
GCLC Antibody (Center) - Product info | |
| Application | WB
|
| Primary Accession | P48506 |
| Other Accession | P19468, P97494, NP_001489.1 |
| Reactivity | Human, Mouse |
| Predicted | Rat |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 72766 Da |
GCLC Antibody (Center) - Additional info | |
| Gene ID 2729 | |
| Other Names GCLC; GLCL; GLCLC; Glutamate--cysteine ligase catalytic subunit; GCS heavy chain; Gamma-ECS; Gamma-glutamylcysteine synthetase | |
| Target/Specificity This GCLC antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 285-315 amino acids from the Central region of human GCLC. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions GCLC Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures. | |
GCLC Antibody (Center) - Protein Information | |
| Name GCLC | |
| Synonyms GLCL, GLCLC | |
GCLC Antibody (Center) - Related products
AP11943a: GCLC Antibody (N-term)
AP18483c: GCLC Antibody (Center)
DC05276: Human GCLC cDNA Clone
GCLC Antibody (Center) - Application data
-
GCLC Antibody (Center) (Cat. #AP18483c) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the GCLC antibody detected the GCLC protein (arrow).
-
GCLC Antibody (Center) (Cat. #AP18483c) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the GCLC antibody detected the GCLC protein (arrow).
GCLC Antibody (Center) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.
REFERENCES
Man, B.L., et al. J Clin Neurosci 17(10):1244-1247(2010) Jia, P., et al. Schizophr. Res. 122 (1-3), 38-42 (2010) : Le, T.M., et al. Mol. Genet. Metab. 101(1):55-61(2010) Fullerton, J.M., et al. Bipolar Disord 12(5):550-556(2010) Wang, X., et al. PLoS ONE 5 (8), E11934 (2010) :
